MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$13.68+0.13 (+0.96%)
Close on Nov 17, 2026Market cap $175.58MP/E –Yield –
MediWound gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 19.2%, against 13.0% the year before. The highest annual figure on record is 62.7% in fiscal 2019.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19.2% | +6.2 |
| FY2024 | Dec 31, 2024 | 13.0% | −6.1 |
| FY2023 | Dec 31, 2023 | 19.1% | −30.5 |
| FY2022 | Dec 31, 2022 | 49.7% | +12.8 |
| FY2021 | Dec 31, 2021 | 36.9% | +2.2 |
| FY2020 | Dec 31, 2020 | 34.7% | −28.1 |
| FY2019 | Dec 31, 2019 | 62.7% | +24.1 |
| FY2018 | Dec 31, 2018 | 38.6% | +1.8 |
| FY2017 | Dec 31, 2017 | 36.8% | +75.3 |
| FY2016 | Dec 31, 2016 | -38.5% | +280.6 |
| FY2015 | Dec 31, 2015 | -319.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 10.9% | −12.9 |
| Q2 FY2025 | Jun 30, 2025 | 23.5% | −15.5 |
| Q2 FY2024 | Jun 30, 2024 | 8.8% | −21.4 |
| Q2 FY2023 | Jun 30, 2023 | 23.8% | −59.4 |
| Q2 FY2022 | Jun 30, 2022 | 23.8% | −15.1 |
| Q2 FY2021 | Jun 30, 2021 | 39.0% | +9.4 |
| Q2 FY2020 | Jun 30, 2020 | 30.2% | – |
| Q2 FY2019 | Jun 30, 2019 | 83.2% | – |
| Q2 FY2018 | Jun 30, 2018 | 39.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 29.5% | – |
See a number that looks wrong?